Douglas Lane & Associates LLC Has $142.12 Million Stock Holdings in Morgan Stanley $MS

Douglas Lane & Associates LLC cut its position in shares of Morgan Stanley (NYSE:MS) by 5.6% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 800,539 shares of the financial services provider’s stock after selling 47,889 shares during the period. Morgan Stanley comprises 2.0% of Douglas Lane & Associates LLC’s portfolio, making the stock its 6th biggest position. Douglas Lane & Associates LLC owned 0.05% of Morgan Stanley worth $142,120,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Olistico Wealth LLC bought a new stake in Morgan Stanley during the 4th quarter valued at $27,000. Lodestone Wealth Management LLC bought a new stake in Morgan Stanley during the 4th quarter valued at $28,000. WFA of San Diego LLC purchased a new position in shares of Morgan Stanley in the 2nd quarter valued at $28,000. Greykasell Wealth Strategies Inc. increased its holdings in shares of Morgan Stanley by 65.2% in the 3rd quarter. Greykasell Wealth Strategies Inc. now owns 185 shares of the financial services provider’s stock valued at $29,000 after acquiring an additional 73 shares during the period. Finally, Family Legacy Financial Solutions LLC increased its holdings in shares of Morgan Stanley by 91.9% in the 3rd quarter. Family Legacy Financial Solutions LLC now owns 213 shares of the financial services provider’s stock valued at $34,000 after acquiring an additional 102 shares during the period. 84.19% of the stock is owned by institutional investors.

Morgan Stanley Stock Up 1.3%

Shares of MS stock opened at $178.29 on Friday. Morgan Stanley has a 1-year low of $102.89 and a 1-year high of $192.68. The stock’s fifty day moving average price is $168.38 and its 200 day moving average price is $169.63. The company has a debt-to-equity ratio of 3.39, a current ratio of 0.81 and a quick ratio of 0.81. The company has a market cap of $281.94 billion, a price-to-earnings ratio of 17.46, a price-to-earnings-growth ratio of 1.41 and a beta of 1.19.

Morgan Stanley (NYSE:MS) last announced its earnings results on Thursday, January 15th. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.28 by $0.40. Morgan Stanley had a return on equity of 16.78% and a net margin of 14.09%.The firm had revenue of $17.90 billion for the quarter, compared to the consensus estimate of $17.69 billion. During the same period in the previous year, the business earned $2.22 EPS. The firm’s revenue for the quarter was up 10.3% on a year-over-year basis. On average, research analysts expect that Morgan Stanley will post 8.56 earnings per share for the current fiscal year.

Morgan Stanley Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, February 13th. Investors of record on Friday, January 30th were paid a dividend of $1.00 per share. This represents a $4.00 annualized dividend and a yield of 2.2%. The ex-dividend date was Friday, January 30th. Morgan Stanley’s payout ratio is 39.18%.

Morgan Stanley News Roundup

Here are the key news stories impacting Morgan Stanley this week:

• Positive Sentiment: Morgan Stanley launched the Morgan Stanley Bitcoin Trust (MSBT), the first spot Bitcoin ETP issued by a major U.S. bank, giving the firm a new fee‑earning product and a distribution advantage via ~16,000 financial advisors. This broadens MS’s wealth-management monetization and strategic product set. Article Title
• Positive Sentiment: MSBT had a solid debut with roughly $30–34M of first‑day inflows/trading volume and is priced competitively (0.14% fee), helping MS capture market share in the fast‑growing crypto ETF category and supporting revenue growth for its asset-management platform. Article Title
• Positive Sentiment: Analyst support: UBS upgraded Morgan Stanley and other brokers (Goldman previously raised a target) have nudged sentiment; some firms also raised EPS/earnings estimates, which helps the investment case around MS’s wealth management and trading franchises. Upgrades/positive notes add to demand. Article Title
• Neutral Sentiment: Underlying fundamentals remain supportive: coverage notes and earnings‑growth previews (and consensus EPS upgrades from some shops) highlight that MS’s fee‑based wealth business and trading could sustain earnings momentum into upcoming reports. These are background positives but not immediate catalysts. Article Title
• Neutral Sentiment: Research & sector actions: Morgan Stanley research continues to move coverage on other financial and insurance names (P&C targets, etc.), which highlights active research flows but is tangential to MS’s stock performance. Article Title
• Negative Sentiment: Crypto ETF flows remain mixed: despite MSBT’s debut inflows, the broader U.S. spot‑Bitcoin ETF family recorded net outflows recently — a reminder that demand can be uneven and that MSBT still needs sustained inflows to meaningfully add fee revenue. That creates short‑term execution risk. Article Title
• Negative Sentiment: Some sell‑side firms trimmed price targets (e.g., Daiwa lowered MS’s target recently), which can cap upside for traders focused on near‑term valuations and may explain profit‑taking by some holders. Article Title

Wall Street Analysts Forecast Growth

MS has been the topic of a number of analyst reports. UBS Group upgraded Morgan Stanley from a “neutral” rating to a “buy” rating and lifted their price target for the company from $195.00 to $196.00 in a report on Tuesday. JPMorgan Chase & Co. lifted their price target on Morgan Stanley from $173.00 to $179.00 and gave the company a “neutral” rating in a report on Tuesday, March 10th. Keefe, Bruyette & Woods lifted their price target on Morgan Stanley from $202.00 to $210.00 and gave the company a “moderate buy” rating in a report on Friday, January 16th. Wolfe Research cut their price target on Morgan Stanley from $221.00 to $197.00 and set an “outperform” rating on the stock in a report on Wednesday, April 1st. Finally, Rothschild & Co Redburn cut their price target on Morgan Stanley from $175.00 to $171.00 and set a “neutral” rating on the stock in a report on Wednesday, April 1st. Eight analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $189.94.

Insider Activity

In related news, insider Michael A. Pizzi sold 20,000 shares of the business’s stock in a transaction on Tuesday, January 20th. The stock was sold at an average price of $184.55, for a total transaction of $3,691,000.00. Following the transaction, the insider directly owned 127,872 shares in the company, valued at $23,598,777.60. The trade was a 13.53% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Sharon Yeshaya sold 15,838 shares of the business’s stock in a transaction on Tuesday, January 20th. The stock was sold at an average price of $185.77, for a total value of $2,942,225.26. Following the transaction, the chief financial officer owned 135,304 shares in the company, valued at approximately $25,135,424.08. This trade represents a 10.48% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 129,191 shares of company stock worth $23,736,506 over the last quarter. Company insiders own 0.19% of the company’s stock.

Morgan Stanley Company Profile

Morgan Stanley (NYSE: MS) is a global financial services firm headquartered in New York City. Founded in 1935 by Henry S. Morgan and Harold Stanley, the company provides a broad range of investment banking, securities, wealth management and investment management services to corporations, governments, institutions and individual investors. Leadership has been guided by a senior executive team and board of directors; James P. Gorman has served as the company’s chief executive and chairman in recent years.

The firm’s primary business activities are organized around three principal businesses: Institutional Securities, Wealth Management and Investment Management.